Functional evaluation of cholesterol level reduction in humans - Functional evaluation of cholesterol level reduction in humans

EP Mediate Co., Ltd.0 个研究点目标入组 60 人开始时间: 2022年7月4日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Those who regularly intake foods, health foods, or medicines that are rich in active ingredients of research foods. (2) Those who are currently, or within the past 3 months have been, in the habit of continuously intaking foods with functional claims or health foods that claim to be related to lipid or glucose metabolism, or are planning to intake such foods during the study period. (3) Those with a history of dyslipidemia, hypertension, diabetes, psychiatric disorders, sleep disorders, or serious illnesses, or a history of continuous drug treatment. (4) Those with a BMI of 30 kg/m2 or higher. (5) Those who are at risk of developing allergies related to the research. (6) Those whose daily alcohol consumption exceeds an average of 60 g/day of pure alcohol equivalent. (7) Those who are judged to be unsuitable as a subject based on the results of the lifestyle questionnaire. (8) Those whose physical measurements, physical test values, and clinical test values before the start of ingestion show significant deviations from the standard range. (9) Those who are currently participating in other clinical tests, or those who have not passed 3 months after participation in other clinical tests. (10) Those who plan to become pregnant or breastfeed during the study period. (11) Those who are likely to change their lifestyle during the study period (e.g., long trips, etc.). (12) Any other person who is judged as inappropriate as a subject by the Chief Medical Officer.

发起方